Page Header

The Looming Success in Cancer Vaccination

Shafkat Shamim Rahman

Abstract


Cancer vaccination projects are on trial worldwide and the results are far-off being a remarkable success. Albeit, thousands of clinical trials are taking place, only a several of those are producing a significant result to increase the survival rate of the patients. Four vaccines (Human papillomavirus - HPV vaccines, Hepatitis B virus - HBV vaccines, Sipuleucel-T and Oncophage) are approved for market in the United States and Russia so far. Most of the prototype vaccines are yielding at phase III clinical trials after being successful at phase I and II. Apparently, new visions and approaches are required to guide these projects to harvest better results.


Keywords


Vaccination; cancer; clinical trial

Full Text:

PDF


DOI: http://dx.doi.org/10.18686/aem.v0.137

Refbacks

  • There are currently no refbacks.


Copyright (c) 2018 Shafkat Shamim Rahman

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.